Protease Inhibitors

Cysteine protease inhibitor: membrane-impermeable calpain inhibitor. Significantly reduces calpain-mediated depletion of microtubule-associated protein (MAP2) in an animal model of an ischemic brain.

Cysteine protease inhibitor: membrane-impermeable calpain inhibitor. Significantly reduces calpain-mediated depletion of microtubule-associated protein (MAP2) in an animal model of an ischemic brain.

Cysteine protease inhibitor: membrane-impermeable calpain inhibitor. Significantly reduces calpain-mediated depletion of microtubule-associated protein (MAP2) in an animal model of an ischemic brain.

Cysteine protease inhibitor: membrane-impermeable calpain inhibitor. Significantly reduces calpain-mediated depletion of microtubule-associated protein (MAP2) in an animal model of an ischemic brain.

A synthetic analog of E-64, a potent and irreversible cysteine protease inhibitor inhibits cathepsin B and L from rat liver with IC50 values of 8.7 and 3.5 nM, respectively.

A synthetic analog of E-64, a potent and irreversible cysteine protease inhibitor inhibits cathepsin B and L from rat liver with IC50 values of 8.7 and 3.5 nM, respectively.

Irreversible cell-permeable cathepsin B and L inhibitor.

Irreversible cell-permeable cathepsin B and L inhibitor.

Irreversible cell-permeable cathepsin B and L inhibitor.

Irreversible cell-permeable cathepsin B and L inhibitor.

Irreversible cell-permeable cathepsin B and L inhibitor.

Irreversible cell-permeable cathepsin B and L inhibitor.